Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-122136

Chief Development Officer sold 11,767 shares at $36.01 ($423,730)

  • Chief Development Officer acquired 11,767 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2026-03-20 Option exercise 10b5-1 +11,767 $21.65 $254,756 13,998 D: show line 1 in the form
Guyer William Chief Development Officer 2026-03-20 Sale 10b5-1 −11,767 $36.01 $423,730 2,231 D: show line 2 in the form
Open-market sales · 11,767 sh · avg $36.01 · $423,730

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Guyer William Chief Development Officer 2026-03-20 Option exercise · Stock Option (right to buy) 10b5-1 −11,767 210,000 D: show line 3 in the form
Loading xslF345X06/ownership.xml…